ArticleFrontiers in public health2021
Epidemiological Characteristics and Transmissibility of Human Immunodeficiency Virus in Nanning City, China, 2001-2020.
Abstract read
In one paragraph
Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Assessing three-decade HIV testing transformation: TOPSIS-radar evaluation of tiered health system performance in rural-urban Southwestern China.BMC public health · 2025Article
- Effectiveness of human immunodeficiency virus prevention strategies by mapping the geographic dispersion pattern of human immunodeficiency virus prevalence in Nanning, China.BMC public health · 2024Article
- Tuberculosis among Ambulatory People Living with HIV in Guangxi Province, China: A Longitudinal Study.International journal of environmental research and public health · 2022Article
- Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study.Journal of medical virology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Qian LinDevelopment Planning Office, Guangxi Medical University, Nanning, China.
Bin DengDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Jia RuiDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Song-Bai GuoDepartment of Mathematics and Data Science, School of Science, Beijing University of Civil Engineering and Architecture, Beijing, China.
Qingqing HuDivision of Public Health, School of Medicine, University of Utah, 201 Presidents Circle, Salt Lake, UT, United States.
Qiuping ChenLaboratory Intertryp CIRAD/IRD, Université de Montpellier, Montpellier, France.
Chi TangDivision of Director's Office, Nanning Municipal Health Commission, Nanning, China.
Lina ZhouDepartment of Nephrology, The Second Hospital of Xiamen Medical College, Xiamen, China.
Zeyu ZhaoDevelopment Planning Office, Guangxi Medical University, Nanning, China.
Shengnan LinDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Yuanzhao ZhuDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Meng YangDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Yao WangDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Jingwen XuDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Xingchun LiuDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Tianlong YangDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Peihua LiDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Zhuoyang LiDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Li LuoDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Weikang LiuDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Chan LiuDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Jiefeng HuangDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Min YaoDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Mengni NongDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Liping NongDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Jinglan WuDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Na LuoDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Shihai ChenDivision of Director's Office, Nanning Municipal Health Commission, Nanning, China.
Roger FrutosDepartment of Medical Insurance Office, Xiang'an Hospital of Xiamen University, Xiamen, China.
Shixiong YangDepartment of STD and AIDS Prevention and Treatment, Nanning Center for Disease Control and Prevention, Nanning, China.
Qun LiDepartment of Health Emergency, Chinese Center for Disease Control and Prevention, Beijing, China.
Jing-An CuiDepartment of Mathematics and Data Science, School of Science, Beijing University of Civil Engineering and Architecture, Beijing, China.
Tianmu ChenDepartment of Science and Technology, School of Public Health, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen University, Xiamen, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
HIV InfectionsBasic Reproduction NumberChinaHIVHumansacquired immune deficiency syndromedynamicshuman immunodeficiency virustransmissibilitytransmission model
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.